Mary Ann Liebert, Inc., publishers

07/01/2025

Happening TODAY!

Dive into "Tiny Traces, Big Impact: Revolutionizing Breast Cancer Management with MRD Testing"

⏰ Time: 1:00 pm PT | 4:00 pm ET | 10:00 CET

Join us, alongside Natera and Mary Ann Liebert, Inc., to discover how MRD testing is reshaping adjuvant therapy decisions. This is your chance to learn and engage with industry leaders!

Register Here https://hubs.li/Q03rz7lD0

06/27/2025

🎉 Milestone unlocked: 50,000+ full-text downloads for AI in Precision Oncology!

This newly launched journal is already making an impact at the cutting edge of AI and individualized cancer care.

Led by Editor-in-Chief Douglas Flora, MD and Deputy Editor Nikhil Thaker, MD, the journal champions innovation, equity, and real-world application—with a powerhouse editorial board behind it. 💡🧬

Thank you to the contributors, readers, and editorial board members helping make this a vital space for collaboration and discovery.

More to come as we continue building a collaborative, real-world-impact forum for the future of AI in oncology.

📖 Explore the journal: https://hubs.li/Q03v3R6F0

06/25/2025

DON'T MISS OUT!
Join us for "Tiny Traces, Big Impact: Revolutionizing Breast Cancer Management with MRD Testing"

🗓️ Mark Your Calendar: Tuesday, July 1st, 2025
⏰ Time: 1:00 pm PT | 4:00 pm ET | 10:00 CET

Proudly sponsored by Natera and hosted by Mary Ann Liebert, Inc., this webinar will explore how MRD testing is transforming adjuvant therapy decisions. Don't miss out on this opportunity to learn and engage!

Secure your spot now: Register Here https://hubs.li/Q03sVGxk0 and join the conversation!

06/13/2025

🌈 Celebrate Pride with Open-Access Research

This Pride Month, we’re proud to share a special collection of articles exploring LGBTQ+ identity, health, and equity. These peer-reviewed studies spotlight diverse experiences—from the intersection of queerness and neurodiversity to racial inequities in youth mental health.

📖 Start reading: https://hubs.li/Q03s0cvp0

🧠 Topics include:
• Gender-affirming surgery
• Depression and school connectedness
• LGBTQ+ Autistic identities
• Let’s champion inclusive, evidence-based research.

06/11/2025

Today's the day! Don't forget to register for GEN's State of CRISPR & Genome Editing virtual summit, kicking off at 11am ET. Hear from industry experts as they discuss the latest scientific, technology, commercial and regulatory advances that will enable genome editing to unleash its full potential in the clinic and beyond.

In his session, Fyodor Urnov PhD reflects on the inspiring "Baby KJ" story and last week's extraordinary meeting between cell and gene therapy scientists and the new FDA/HHS leadership, as the community seeks to try more recipes from the "CRISPR Cures" cookbook.

To register for free, visit:
https://hubs.li/Q03rC6HX0

06/11/2025

NEW WEBINAR!
Tiny Traces, Big Impact: Changing the Paradigm in Breast Cancer Management with MRD Testing

Broadcast Date: Tuesday, July 1st, 2025
Time: 1:00 pm PT, 4:00 pm ET, 10:00 CET

Sponsored by Natera and hosted by Mary Ann Liebert, Inc. Discover how MRD testing is being integrated as a reliable decision-making tool to guide adjuvant therapy decisions with the goal of right-sizing treatment. REGISTER NOW! https://hubs.li/Q03rz4TX0 and be part of the conversation!

06/09/2025

In case you missed it: Michael Pollan’s latest article in The New Yorker, “This Is Your Priest on Drugs,” explores an extraordinary Johns Hopkins study on psilocybin’s impact on spiritual leadership.

We’re proud this study was published in Psychedelic Medicine, reinforcing the journal’s leadership at the intersection of science, spirituality, and mental health.

📖 Read the feature: https://hubs.li/Q03rkbC20
🔬 Read the study: https://hubs.li/Q03rk92b0

A sincere thank you to Editors-in-Chief Dr. Peter Hendricks and Dr. Charles Nichols for their visionary leadership.

Dozens of religious leaders experienced magic mushrooms in a university study. Many are now evangelists for psychedelics.

06/09/2025

🧠 Insights from the Experts
Join global leaders in gene editing—including Dr. Feng Zhang—at The State of CRISPR and Gene Editing 2025 virtual summit. Hear about the latest scientific, technology, commercial and regulatory advances that will enable genome editing to unleash its full potential in the clinic and beyond.
🗓️ Date: June 11, 2025
🕒 Time: 11:00 AM - 3:30 PM (ET)
🔗 Register Now for FREE: https://hubs.ly/Q03rgZfH0

06/06/2025

New Open-Access Resource for Acupuncture Researchers

The Topological Atlas and Repository for Acupoint Research (TARA) is an innovative new database that allows scientists to deposit, share, and compare data on acupuncture points. Developed with funding from the National Center for Complementary and Integrative Health, TARA is poised to advance our understanding of acupoint mechanisms.

In Medical Acupuncture, Dr. Helene Langevin highlights how TARA can support data synthesis across disciplines and shed light on how stimulation of the body’s surface affects internal systems like the interstitium and nervous system.

📖 Read the article: https://hubs.li/Q03r8kG-0

06/04/2025

Register now for the State of CRISPR & Genome Editing virtual summit, hosted by GEN, happening on June 11th! Closing the summit, Beth Shapiro PhD, Chief Scientific Officer at Colossal Biosciences, will give an exclusive in-depth interview discussing ancient DNA, the de-extinction debate, and Colossal's claims regarding the use of multiplex genome editing to create 'dire wolf' cubs.

To register for this free event, visit:
https://hubs.li/Q03qHw150

06/03/2025

Unlock the Future of Healthcare!

Join us for an exclusive webinar, "Tails of Innovation: Transforming RNA Therapeutics with Cutting-Edge Poly(A) Modifications." 🧬

🗓️ TODAY: Tuesday, June 3rd, 2025
⏰ Time: 8:00 am PT | 11:00 am ET | 17:00 CET

Hosted by TriLink BioTechnologies and Mary Ann Liebert, Inc., this is your opportunity to dive into revolutionary genetic engineering breakthroughs with leading experts. Curious about how these innovations could change the face of healthcare? Don’t wait—reserve your spot now! REGISTER NOW: https://hubs.li/Q03jDx1G0

06/02/2025

🧠 A major step forward in brain injury research

When someone experiences a traumatic brain injury (TBI)—whether from a fall, accident, or sports injury—health professionals often struggle to consistently describe and classify what’s happening in the brain.

The National Institute of Neurological Disorders and Stroke (NINDS) has just launched a new initiative to change that. Their TBI Classification and Nomenclature Initiative, published in Journal of Neurotrauma, introduces a standardized way to define and categorize acute TBIs.

This new system helps researchers and clinicians speak the same language, improving how we study TBI and how we care for patients in the future.

📘 Read more:
https://hubs.li/Q03qbCTS0